Equity Research, Broker Reports, and media content on Allergy Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics. We currently have 208 research reports from 9 professional analysts.

Open
10.2p
Range Today
10.1/10.4p
52 Week
7.38/15.5p
Daily Volume
134.6k
# Shares
636.2m
Daily Liquidity
(0.02%)
Pension Liability
£9.52m
Enterprise Value
£56.7m
Market Cap
£65.2m
Latest PE (hist)
23.36
Div Yield
Date Source Announcement
01Apr20 13:09 RNS Grant and Vesting of Awards
09Mar20 07:15 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
04Mar20 07:00 RNS Half-year Report
29Jan20 12:00 RNS Data for peanut allergy vaccine published in JACI
16Jan20 12:25 RNS Trading Update & Notice of Results - Replacement
16Jan20 08:00 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
16Jan20 07:00 RNS Half Year Trading Update & Notice of Results
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics

  • Providers covering

    Allergy Therapeutics